When was DIAsource ImmunoAssays S.A. founded?

DIAsource ImmunoAssays S.A. was founded on 23 May 1996, making it 30 years old.

Is DIAsource ImmunoAssays S.A. still active?

Yes, DIAsource ImmunoAssays S.A. is currently active.

Where is DIAsource ImmunoAssays S.A. registered?

DIAsource ImmunoAssays S.A.'s registered address is Rue du Bosquet 2, 1348 Ottignies-Louvain-la-Neuve, Belgium.

How many employees does DIAsource ImmunoAssays S.A. have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), DIAsource ImmunoAssays S.A. reported 80.9 full-time equivalent employees.

What is DIAsource ImmunoAssays S.A.'s annual turnover?

DIAsource ImmunoAssays S.A.'s most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €16,705,157.

Did DIAsource ImmunoAssays S.A. make a profit or a loss?

DIAsource ImmunoAssays S.A.'s most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a loss of €1,080,460.

When did DIAsource ImmunoAssays S.A. last file annual accounts?

DIAsource ImmunoAssays S.A.'s most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is DIAsource ImmunoAssays S.A. B Corp certified?

We have no B Corp certification on file for DIAsource ImmunoAssays S.A..

Does DIAsource ImmunoAssays S.A. hold Fairtrade certification?

No, DIAsource ImmunoAssays S.A. does not currently hold Fairtrade certification.

DIAsource ImmunoAssays S.A.

Q: What does DIAsource ImmunoAssays S.A. do?

DIAsource ImmunoAssays S.A.'s registered main activities are Manufacture of other pharmaceutical products, Diagnostic imaging services and medical laboratory activities, Research and experimental development on biotechnology, Non-specialised wholesale trade, Wholesale of pharmaceutical and medical goods, Wholesale of chemical products for industrial use, and Manufacture of other chemical products n.e.c..

BE 0457.934.723

Copied!

NV/SA

Status

Active

Founded

23 May 1996

Size

Medium · 80.9 FTE

Age

30 yrs

Main activity

Manufacture of other pharmaceutical products

Activities

7 activities

Manufacture of other pharmaceutical productsDiagnostic imaging services and medical laboratory activitiesResearch and experimental development on biotechnologyNon-specialised wholesale tradeWholesale of pharmaceutical and medical goodsWholesale of chemical products for industrial useManufacture of other chemical products n.e.c.

Financials

Turnover2025

€16.7M-4.2%

Profit / Loss2025

−€1.1M-842%

Equity2025

€4.4M-19.7%

2025	2024	2022	2021
€16,705,157-4.2%	€17,435,033-1.3%	€17,662,828+6.5%	€16,582,992
-€1,080,460-842%	€145,613+349.7%	-€58,314-107%	€836,978
€4,408,904-19.7%	€5,489,364+2.3%	€5,368,077-1.1%	€5,426,391
€5,674,376-6.1%	€6,040,404-29%	€8,513,817-18.6%	€10,465,419
€407,712-41.6%	€698,029+41.9%	€491,831-70%	€1,638,507
80.9-3.8%	84.1+5.4%	79.8+4.5%	76.4
€206,491-0.4%	€207,313-6.3%	€221,339+2%	€217,055

Frequently asked questions

01What is DIAsource ImmunoAssays S.A.'s official registered name?

DIAsource ImmunoAssays S.A..

02What is DIAsource ImmunoAssays S.A.'s enterprise number (VAT number)?

BE 0457.934.723.

03What is DIAsource ImmunoAssays S.A.'s legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

Financial statements

	2025	2024	2022	2021
Income statement
	€16,705,157-4.2%	€17,435,033-1.3%	€17,662,828+6.5%	€16,582,992
	80.9-3.8%	84.1+5.4%	79.8+4.5%	76.4
	€206,491-0.4%	€207,313-6.3%	€221,339+2%	€217,055
	€7,627,392+10.7%	€6,893,243+11.4%	€6,188,693+2.7%	€6,026,986
	-€739,204-231.7%	€561,149+124%	€250,535-80.6%	€1,288,740
	€606,606-67.4%	€1,861,434+1.7%	€1,830,657-27.7%	€2,532,272
	€215,350	—	—	—
	-€1,080,460-842%	€145,613+349.7%	-€58,314-107%	€836,978
	€183,007-12%	€207,948-43%	€364,672-7%	€391,964
Profitability
	3.6%-66%	10.7%+3%	10.4%-32.1%	15.3%
	-6.5%-874.4%	0.8%+353%	-0.3%-106.5%	5.0%
	-24.5%<-1000%	2.7%+344.2%	-1.1%-107%	15.4%
	-10.7%-952.1%	1.3%+399.4%	-0.4%-108%	5.3%
Solvency
	€10,083,280-12.9%	€11,579,769-16.6%	€13,881,894-12.6%	€15,891,811
	€1,773,132-6.9%	€1,903,838-13.4%	€2,199,416-1%	€2,220,941
	€210,0000%	€210,0000%	€210,0000%	€210,000
	€4,408,904-19.7%	€5,489,364+2.3%	€5,368,077-1.1%	€5,426,391
	43.7%-7.8%	47.4%+22.6%	38.7%+13.3%	34.1%
	€820,925-48.8%	€1,603,397-53.2%	€3,428,262-24.8%	€4,560,963
	0.19-36.2%	0.29-54.3%	0.64-24%	0.84
	€5,674,376-6.1%	€6,040,404-29%	€8,513,817-18.6%	€10,465,419
	1.29+17%	1.10-30.6%	1.59-17.8%	1.93
	-2.59-233.2%	1.94+104.2%	0.95-80.9%	4.99
Liquidity
	€407,712-41.6%	€698,029+41.9%	€491,831-70%	€1,638,507
	€3,816,224-3.4%	€3,949,165-0.5%	€3,970,706+14.5%	€3,467,141
	€2,968,159-0.2%	€2,974,615+8.5%	€2,742,644-0.9%	€2,766,691
	€1,512,667-12.4%	€1,727,113-22.9%	€2,241,183+32.1%	€1,697,216
	€4,837,314+9.5%	€4,418,744-12.2%	€5,031,012-14.1%	€5,856,338
	1.45-10.7%	1.62+17%	1.38+25.2%	1.11
	€2,568,957-25.4%	€3,443,619+40.9%	€2,444,228+8.1%	€2,260,569
Efficiency
	65 days+4.1%	62 days+9.9%	57 days-6.9%	61 days
	64 days-12.7%	73 days-14.6%	86 days+8.8%	79 days
	260 days-4.6%	273 days+14.5%	238 days-4%	248 days
	1.38+3%	1.34-18.3%	1.64	—
Profit appropriation
	€956,9890%	€956,9890%	€956,9890%	€956,989
	€1,382,024-43.9%	€2,462,485+5.2%	€2,341,198-2.4%	€2,399,512

Sources

NBB — Nationale Bank van België

	2025	2024	2022	2021
Income statement
	€16,705,157-4.2%	€17,435,033-1.3%	€17,662,828+6.5%	€16,582,992
	80.9-3.8%	84.1+5.4%	79.8+4.5%	76.4
	€206,491-0.4%	€207,313-6.3%	€221,339+2%	€217,055
	€7,627,392+10.7%	€6,893,243+11.4%	€6,188,693+2.7%	€6,026,986
	-€739,204-231.7%	€561,149+124%	€250,535-80.6%	€1,288,740
	€606,606-67.4%	€1,861,434+1.7%	€1,830,657-27.7%	€2,532,272
	€215,350	—	—	—
	-€1,080,460-842%	€145,613+349.7%	-€58,314-107%	€836,978
	€183,007-12%	€207,948-43%	€364,672-7%	€391,964
Profitability
	3.6%-66%	10.7%+3%	10.4%-32.1%	15.3%
	-6.5%-874.4%	0.8%+353%	-0.3%-106.5%	5.0%
	-24.5%<-1000%	2.7%+344.2%	-1.1%-107%	15.4%
	-10.7%-952.1%	1.3%+399.4%	-0.4%-108%	5.3%
Solvency
	€10,083,280-12.9%	€11,579,769-16.6%	€13,881,894-12.6%	€15,891,811
	€1,773,132-6.9%	€1,903,838-13.4%	€2,199,416-1%	€2,220,941
	€210,0000%	€210,0000%	€210,0000%	€210,000
	€4,408,904-19.7%	€5,489,364+2.3%	€5,368,077-1.1%	€5,426,391
	43.7%-7.8%	47.4%+22.6%	38.7%+13.3%	34.1%
	€820,925-48.8%	€1,603,397-53.2%	€3,428,262-24.8%	€4,560,963
	0.19-36.2%	0.29-54.3%	0.64-24%	0.84
	€5,674,376-6.1%	€6,040,404-29%	€8,513,817-18.6%	€10,465,419
	1.29+17%	1.10-30.6%	1.59-17.8%	1.93
	-2.59-233.2%	1.94+104.2%	0.95-80.9%	4.99
Liquidity
	€407,712-41.6%	€698,029+41.9%	€491,831-70%	€1,638,507
	€3,816,224-3.4%	€3,949,165-0.5%	€3,970,706+14.5%	€3,467,141
	€2,968,159-0.2%	€2,974,615+8.5%	€2,742,644-0.9%	€2,766,691
	€1,512,667-12.4%	€1,727,113-22.9%	€2,241,183+32.1%	€1,697,216
	€4,837,314+9.5%	€4,418,744-12.2%	€5,031,012-14.1%	€5,856,338
	1.45-10.7%	1.62+17%	1.38+25.2%	1.11
	€2,568,957-25.4%	€3,443,619+40.9%	€2,444,228+8.1%	€2,260,569
Efficiency
	65 days+4.1%	62 days+9.9%	57 days-6.9%	61 days
	64 days-12.7%	73 days-14.6%	86 days+8.8%	79 days
	260 days-4.6%	273 days+14.5%	238 days-4%	248 days
	1.38+3%	1.34-18.3%	1.64	—
Profit appropriation
	€956,9890%	€956,9890%	€956,9890%	€956,989
	€1,382,024-43.9%	€2,462,485+5.2%	€2,341,198-2.4%	€2,399,512

2025

2024

2022

2021

Income statement

€16,705,157-4.2%

€17,435,033-1.3%

€17,662,828+6.5%

€16,582,992

80.9-3.8%

84.1+5.4%

79.8+4.5%

76.4

€206,491-0.4%

€207,313-6.3%

€221,339+2%

€217,055

€7,627,392+10.7%

€6,893,243+11.4%

€6,188,693+2.7%

€6,026,986

-€739,204-231.7%

€561,149+124%

€250,535-80.6%

€1,288,740

€606,606-67.4%

€1,861,434+1.7%

€1,830,657-27.7%

€2,532,272

€215,350

—

-€1,080,460-842%

€145,613+349.7%

-€58,314-107%

€836,978

€183,007-12%

€207,948-43%

€364,672-7%

€391,964

Profitability

3.6%-66%

10.7%+3%

10.4%-32.1%

15.3%

-6.5%-874.4%

0.8%+353%

-0.3%-106.5%

5.0%

-24.5%<-1000%

2.7%+344.2%

-1.1%-107%

15.4%

-10.7%-952.1%

1.3%+399.4%

-0.4%-108%

5.3%

Solvency

€10,083,280-12.9%

€11,579,769-16.6%

€13,881,894-12.6%

€15,891,811

€1,773,132-6.9%

€1,903,838-13.4%

€2,199,416-1%

€2,220,941

€210,0000%

€210,000

€4,408,904-19.7%

€5,489,364+2.3%

€5,368,077-1.1%

€5,426,391

43.7%-7.8%

47.4%+22.6%

38.7%+13.3%

34.1%

€820,925-48.8%

€1,603,397-53.2%

€3,428,262-24.8%

€4,560,963

0.19-36.2%

0.29-54.3%

0.64-24%

0.84

€5,674,376-6.1%

€6,040,404-29%

€8,513,817-18.6%

€10,465,419

1.29+17%

1.10-30.6%

1.59-17.8%

1.93

-2.59-233.2%

1.94+104.2%

0.95-80.9%

4.99

Liquidity

€407,712-41.6%

€698,029+41.9%

€491,831-70%

€1,638,507

€3,816,224-3.4%

€3,949,165-0.5%

€3,970,706+14.5%

€3,467,141

€2,968,159-0.2%

€2,974,615+8.5%

€2,742,644-0.9%

€2,766,691

€1,512,667-12.4%

€1,727,113-22.9%

€2,241,183+32.1%

€1,697,216

€4,837,314+9.5%

€4,418,744-12.2%

€5,031,012-14.1%

€5,856,338

1.45-10.7%

1.62+17%

1.38+25.2%

1.11

€2,568,957-25.4%

€3,443,619+40.9%

€2,444,228+8.1%

€2,260,569

Efficiency

65 days+4.1%

62 days+9.9%

57 days-6.9%

61 days

64 days-12.7%

73 days-14.6%

86 days+8.8%

79 days

260 days-4.6%

273 days+14.5%

238 days-4%

248 days

1.38+3%

1.34-18.3%

1.64

—

Profit appropriation

€956,9890%

€956,989

€1,382,024-43.9%

€2,462,485+5.2%

€2,341,198-2.4%

€2,399,512

DIAsource ImmunoAssays S.A.

Activities

Financials

Frequently asked questions

All locations

Financial statements

All locations

Financial statements